| Charlotte Brown, | |
|
3811 Ohara St, Pittsburgh, PA 15213-2561 | |
| (412) 383-5137 | |
| Not Available |
| Full Name | Charlotte Brown |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 41 Years |
| Location | 3811 Ohara St, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023254083 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PS008556L (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Advanced Practice Providers | 4082836283 | 18 |
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
Xiaowei Dong, Associate Professor and P1 Curriculum Director at HSC College of Pharmacy, was recently awarded the Maximizing Investigators' Resource Award (MIRA-R35) to continue her research into technologies that improve the effectiveness of oral drugs.
This question and others are addressed in three articles about cosmetic neurology in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.
Health officials say that there will be plenty of flu vaccine available this year, now that the H1N1 pandemic has ended, The Washington Post reports. "The World Health Organization declared an end to the pandemic last month, based on indications that the H1N1 flu was transitioning to a more seasonal virus. Unlike last year, when there was one vaccine for H1N1 flu and another for seasonal flu, this year's vaccine is a 'three-in-one' that includes protection against H1N1 as well as two other strains."
Glioblastoma is the most aggressive brain tumor in adults. Now, it can be treated with neurosurgery, radiotherapy and chemotherapy. Still, the median life expectancy of patients affected with this pathology is no longer than 15 months.
Nuvilex, Inc., announces today that Legacy Biotechnologies, Inc., its joint venture partner in Reme-Flu™, has commenced production of Reme-Flu™ and expects it to be ready for consumer purchase within the next 30 days. Reme-Flu™ is Legacy Biotechnologies' unique 2-part homeopathic flu remedy designed to help treat symptoms of the flu. Initially, Reme-Flu™ will be offered on the top-rated website, www.nutralegacy.com.
› Verified 6 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Xiaowei Dong, Associate Professor and P1 Curriculum Director at HSC College of Pharmacy, was recently awarded the Maximizing Investigators' Resource Award (MIRA-R35) to continue her research into technologies that improve the effectiveness of oral drugs.
This question and others are addressed in three articles about cosmetic neurology in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.
Health officials say that there will be plenty of flu vaccine available this year, now that the H1N1 pandemic has ended, The Washington Post reports. "The World Health Organization declared an end to the pandemic last month, based on indications that the H1N1 flu was transitioning to a more seasonal virus. Unlike last year, when there was one vaccine for H1N1 flu and another for seasonal flu, this year's vaccine is a 'three-in-one' that includes protection against H1N1 as well as two other strains."
Glioblastoma is the most aggressive brain tumor in adults. Now, it can be treated with neurosurgery, radiotherapy and chemotherapy. Still, the median life expectancy of patients affected with this pathology is no longer than 15 months.
Nuvilex, Inc., announces today that Legacy Biotechnologies, Inc., its joint venture partner in Reme-Flu™, has commenced production of Reme-Flu™ and expects it to be ready for consumer purchase within the next 30 days. Reme-Flu™ is Legacy Biotechnologies' unique 2-part homeopathic flu remedy designed to help treat symptoms of the flu. Initially, Reme-Flu™ will be offered on the top-rated website, www.nutralegacy.com.
› Verified 6 days ago
| Entity Name | Upmc Advanced Practice Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457769176 PECOS PAC ID: 4082836283 Enrollment ID: O20141103001512 |
News Archive
Xiaowei Dong, Associate Professor and P1 Curriculum Director at HSC College of Pharmacy, was recently awarded the Maximizing Investigators' Resource Award (MIRA-R35) to continue her research into technologies that improve the effectiveness of oral drugs.
This question and others are addressed in three articles about cosmetic neurology in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.
Health officials say that there will be plenty of flu vaccine available this year, now that the H1N1 pandemic has ended, The Washington Post reports. "The World Health Organization declared an end to the pandemic last month, based on indications that the H1N1 flu was transitioning to a more seasonal virus. Unlike last year, when there was one vaccine for H1N1 flu and another for seasonal flu, this year's vaccine is a 'three-in-one' that includes protection against H1N1 as well as two other strains."
Glioblastoma is the most aggressive brain tumor in adults. Now, it can be treated with neurosurgery, radiotherapy and chemotherapy. Still, the median life expectancy of patients affected with this pathology is no longer than 15 months.
Nuvilex, Inc., announces today that Legacy Biotechnologies, Inc., its joint venture partner in Reme-Flu™, has commenced production of Reme-Flu™ and expects it to be ready for consumer purchase within the next 30 days. Reme-Flu™ is Legacy Biotechnologies' unique 2-part homeopathic flu remedy designed to help treat symptoms of the flu. Initially, Reme-Flu™ will be offered on the top-rated website, www.nutralegacy.com.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charlotte Brown, 3811 Ohara St, Pittsburgh, PA 15213-2561 Ph: () - | Charlotte Brown, 3811 Ohara St, Pittsburgh, PA 15213-2561 Ph: (412) 383-5137 |
News Archive
Xiaowei Dong, Associate Professor and P1 Curriculum Director at HSC College of Pharmacy, was recently awarded the Maximizing Investigators' Resource Award (MIRA-R35) to continue her research into technologies that improve the effectiveness of oral drugs.
This question and others are addressed in three articles about cosmetic neurology in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.
Health officials say that there will be plenty of flu vaccine available this year, now that the H1N1 pandemic has ended, The Washington Post reports. "The World Health Organization declared an end to the pandemic last month, based on indications that the H1N1 flu was transitioning to a more seasonal virus. Unlike last year, when there was one vaccine for H1N1 flu and another for seasonal flu, this year's vaccine is a 'three-in-one' that includes protection against H1N1 as well as two other strains."
Glioblastoma is the most aggressive brain tumor in adults. Now, it can be treated with neurosurgery, radiotherapy and chemotherapy. Still, the median life expectancy of patients affected with this pathology is no longer than 15 months.
Nuvilex, Inc., announces today that Legacy Biotechnologies, Inc., its joint venture partner in Reme-Flu™, has commenced production of Reme-Flu™ and expects it to be ready for consumer purchase within the next 30 days. Reme-Flu™ is Legacy Biotechnologies' unique 2-part homeopathic flu remedy designed to help treat symptoms of the flu. Initially, Reme-Flu™ will be offered on the top-rated website, www.nutralegacy.com.
› Verified 6 days ago
Lori Siegel Hausman, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4 Allegheny Ctr Fl 8, Pittsburgh, PA 15212 Phone: 412-330-4000 Fax: 412-330-4366 | |
Dr. Morgen A. R. Kelly, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Vaphs, University Drive C, Stop Code: 122-g, Pittsburgh, PA 15240 Phone: 412-822-2971 | |
Loren Pease, Psychologist Medicare: Medicare Enrolled Practice Location: 4401 Penn Ave, Pittsburgh, PA 15224 Phone: 412-692-5097 | |
Mildred Libba Spiegel, MS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 401 Shady Ave, C104, Pittsburgh, PA 15206 Phone: 412-362-7955 Fax: 412-422-8807 | |
Dr. Cynthia A Magistro, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 6315 Forbes Ave, L-120, Pittsburgh, PA 15217 Phone: 412-345-5512 Fax: 412-345-3788 | |
Dr. Michael Craig Clemmens, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 401 Shady Ave Ste A104, Pittsburgh, PA 15206 Phone: 412-441-1683 Fax: 412-361-2295 | |
Dr. Stacey Wettstein, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 401 Shady Ave, 105b, Pittsburgh, PA 15206 Phone: 412-661-4008 |